Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Soroush Sohrabi: Foam or Liquid for Spider Veins?
Soroush Sohrabi /LinkedIn
Mar 14, 2026, 15:07

Soroush Sohrabi: Foam or Liquid for Spider Veins?

Soroush Sohrabi, Consultant Vascular and Endovascular Surgeon at NMC Healthcare, shared a post on LinkedIn:

“Foam or Liquid for Spider Veins?

The Evidence Might Surprise You.

We treat telangiectasias every day. We choose between foam and liquid almost instinctively. But when you actually look at the evidence — it’s thinner than you think.

I reviewed approximately 15 publications spanning 1987 to 2024 comparing foam and liquid sclerotherapy for telangiectasias, including the Cochrane systematic review of 10 RCTs involving 484 patients.

Here’s what stands out:

  • Only one study within the Cochrane review directly compared foam to liquid for telangiectasias. It had 20 patients. No statistics were performed. It was unblinded.
  • Foam trends toward better efficacy and fewer sessions — but this has never been confirmed by a well-powered, blinded trial for spider veins specifically.
  • Foam causes more early side effects – more pain in the first hours, more ecchymosis, more hyperpigmentation at one week. All resolve by three months.
  • Concentration matters more than formulation. Using polidocanol or STS above one percent for veins under 1 mm drives most of the reported complications.
  •  Polidocanol is consistently less painful than STS regardless of whether you use foam or liquid. POL causes no more pain than placebo injection.
  • Transient visual disturbances have been reported exclusively with foam – rare but worth discussing during consent.
  • No formal clinical practice guideline makes a direct evidence-graded recommendation comparing foam to liquid for telangiectasias. Existing consensus documents suggest liquid is the preferred approach for C1 disease, with foam acceptable at lower concentrations — but this reflects expert opinion, not high-quality comparative evidence.

The bottom line: we don’t have a definitive answer.

The field has invested heavily in comparing foam vs. liquid for truncal veins, but for the most common indication in cosmetic phlebology — spider veins — the comparative evidence is remarkably weak.

I created a poster summarising these findings. Swipe to see the full breakdown.

What’s your preference in practice — foam or liquid for telangiectasias?

And why? “Soroush Sohrabi: Foam or Liquid for Spider Veins?

Stay updated with Hemostasis Today.

 

 

CosmeticDermatology Health Hematology Hemostasis Hemostasis News Hemostasis Today Hyperpigmentation Phlebology sclerotherapy Soroush Sohrabi Spider Veins SpiderVeins Telangiectasias VascularMedicine VenousDisease
NewsFeed